Calls to Make Europe the Global Leader for Medical Devices

COCIRCOCIR welcomes the report of the European Commission's Exploratory Process on the Future of Medical Devices published on 28 January 2010. The Exploratory Process was coordinated by DG Enterprise and brought together all stakeholders, including COCIR, to identify the challenges facing the medical devices industry.

COCIR welcomes the report's recognition of the health benefits, economic value and innovative potential that the medical technology sector brings to Europe. The report also comprehensively maps the opportunities and challenges facing the sector and has generated key themes for further Commission reflection and action.

The Members of the Exploratory Process endorsed the need for a clear political vision that recognises the importance of the medical device sector as a driver of sustainable healthcare and economic growth. The group agreed that the European Union should act to make Europe the global leader for medical devices by promoting innovation, efficiency and sustainable health outcomes. The outcome of this initiative is fully in line with the COCIR position outlined in our 2008 White Paper 'Towards a sustainable healthcare model'.

COCIR Secretary General, Nicole Denjoy said "We commend the Commission on its approach to developing this high-level report with comprehensive stakeholder engagement and dialogue as this is the only way to really understand the needs and challenges of the healthcare technology sector in Europe. The Exploratory Process initiative summarises for policymakers what healthcare technology can do and how a strong sector in Europe can support the broader European aspiration that citizens live long and healthy lives. COCIR's members stand ready to work together with the Commission, European Parliament and other key stakeholders to drive forward solutions for the issues identified."

The Commission report: http://ec.europa.eu/enterprise/sectors/medicaldevices/files/exploratory_process/final_report_en.pdf

About COCIR
COCIR is the voice of the European Radiological, Electromedical and Healthcare IT Industry. COCIR is a non-profit trade association, founded in 1959, representing the medical technology industry in Europe. COCIR's members play a driving role in developing the future of healthcare in Europe and worldwide. COCIR moved to Brussels in January 2006, establishing a permanent office in Brussels to better represent industry in its relations with the European institutions. In February 2007, COCIR opened a China Desk in Beijing to strengthen its presence and support for its members in China. For more information, visit www.cocir.org.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...